Integrating Early Palliative Care in Advanced SARcoma Patients for Enhanced QUALITY of Life: the SARQUALITY Study
Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The goal of this study is to learn whether early referral to palliative care improves quality of life for patients with advanced sarcoma. Participants enrolled in this study will complete quality of life questionnaires before starting their treatment, and every 6 weeks for 24 weeks.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Signed written and voluntary informed consent.
• Have histologically documented advanced sarcoma, either locally advanced not amenable to curative treatment, or metastatic.
• Age ≥ 18 years.
• Have not received any previous systemic treatment with palliative intent for advanced sarcoma.
• Performance status of 0-2 on the Eastern Cooperative Oncology Group (ECOG) performance scale.
• Life expectancy \> 6 months.
• Willing/able to complete questionnaires.
Locations
Other Locations
Canada
Mount Sinai Hospital
RECRUITING
Toronto
Contact Information
Primary
Clinical Trials Manager
Oncology.Research@sinaihealth.ca
416-586-8440
Time Frame
Start Date: 2024-03-20
Estimated Completion Date: 2027-10
Participants
Target number of participants: 136
Treatments
Experimental: Early Referral to Palliative Care
Other: Standard Treatment
Related Therapeutic Areas
Sponsors
Leads: Mount Sinai Hospital, Canada